Riociguat for the Treatment of Pulmonary Arterial Hypertension Associated With Connective Tissue Disease: Results From PATENT-1 and PATENT-2

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2015-209087
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2010English

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension in Chinese Patients

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2014English

Connective Tissue Disease-Associated Pulmonary Hypertension

Advances in Pulmonary Hypertension
2008English

Selective endothelinA Receptor Antagonism With Sitaxsentan for Pulmonary Arterial Hypertension Associated With Connective Tissue Disease

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2007English

Patent Ductus Arteriosus With Pulmonary Hypertension

Heart
Cardiovascular MedicineCardiology
1955English

Riociguat Is a Novel Medication for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Medical Council
2016English

A Focus on Riociguat in the Treatment of Pulmonary Arterial Hypertension

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2019English

Pulmonary Arterial Hypertension Associated With Systemic Lupus: Results From the French Pulmonary Hypertension Registry

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2018English

Comparison Between Aortitis Syndrome and Mixed Connective Tissue Disease Associated With Pulmonary Hypertension.

Japanese Journal of Clinical Immunology
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy